Please login to the form below

Not currently logged in
Email:
Password:

SOCRATES

This page shows the latest SOCRATES news and features for those working in and with pharma, biotech and healthcare.

Another failed trial knocks back AZ's plan to grow Brilinta

Another failed trial knocks back AZ's plan to grow Brilinta

Its failure comes after Brilinta was unable to show a benefit on outcomes in ischaemic stroke in the SOCRATES trial.

Latest news

  • Bayer and Merck take high-risk heart failure drug into phase III Bayer and Merck take high-risk heart failure drug into phase III

    The decision to press ahead with vericiguat comes even though the drug produced a less-than-stellar performance in the phase II SOCRATES-REDUCED trial.

  • AZ's Brilinta disappoints in stroke trial AZ's Brilinta disappoints in stroke trial

    The results of the SOCRATES trial revealed that Brilinta (ticagrelor) given at a dose of 90mg twice-daily was no more effective than a single 100mg daily dose of aspirin in ... Full results of the SOCRATES trial are scheduled for presentation at the

  • AZ seeks leg up in antiplatelet market with Brilinta antidote AZ seeks leg up in antiplatelet market with Brilinta antidote

    In addition to the reversal agent programme, AZ also has five additional registration studies ongoing in patients with atherothrombotic disease, including the PEGASUS study looking at long-term prevention, SOCRATES in

  • Brilinta bill of health boosts AstraZeneca Brilinta bill of health boosts AstraZeneca

    AZ can now concentrate on promoting the drug in ACS and extending its indications on the back of ongoing studies such as SOCRATES in ischaemic stroke, THEMIS in atherosclerosis and EUCLID

  • The Great Wall

    Listen to Socrates: "Regard your good name as the richest jewel you can possibly be possessed of - for credit is like fire; when once you have kindled it you may easily

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Certainly, not!

    Certainly, not! Conventional wisdom acknowledges the inevitability of uncertainty. And Socrates apparently said something about it too, so it must be right (“ As for me, all I know is that I

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics